Cargando…
The influenza replication blocking inhibitor LASAG does not sensitize human epithelial cells for bacterial infections
Severe influenza virus (IV) infections still represent a major challenge to public health. To combat IV infections, vaccines and antiviral compounds are available. However, vaccine efficacies vary with very limited to no protection against newly emerging zoonotic IV introductions. In addition, the d...
Autores principales: | Wilden, Janine J., van Krüchten, Andre, Gieselmann, Lutz, Hrincius, Eike R., Deinhardt-Emmer, Stefanie, Haupt, Karoline F., Preugschas, Hannah F., Niemann, Silke, Ludwig, Stephan, Ehrhardt, Christina |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7228112/ https://www.ncbi.nlm.nih.gov/pubmed/32413095 http://dx.doi.org/10.1371/journal.pone.0233052 |
Ejemplares similares
-
D,L-Lysine-Acetylsalicylate + Glycine (LASAG) Reduces SARS-CoV-2 Replication and Shows an Additive Effect with Remdesivir
por: Jungwirth, Johannes, et al.
Publicado: (2022) -
Impact of Staphylococcus aureus Small Colony Variants on Human Lung Epithelial Cells with Subsequent Influenza Virus Infection
por: Wilden, Janine J., et al.
Publicado: (2020) -
Inhibition of Phosphatidylinositol 3-Kinase by Pictilisib Blocks Influenza Virus Propagation in Cells and in Lungs of Infected Mice
por: Deinhardt-Emmer, Stefanie, et al.
Publicado: (2021) -
Metabolic Modifications by Common Respiratory Viruses and Their Potential as New Antiviral Targets
por: Kleinehr, Jens, et al.
Publicado: (2021) -
Targeting intracellular signaling as an antiviral strategy: aerosolized LASAG for the treatment of influenza in hospitalized patients
por: Scheuch, Gerhard, et al.
Publicado: (2018)